Skip to main content

ADVERTISEMENT

Toru Naganuma, MD

Original Contribution
06/04/2013
Despite the presence of complex distal left main lesions, new drug-eluting stents appear promising in the treatment of ULMCA disease in terms of safety and efficacy at 2-year clinical follow-up.
Despite the presence of complex distal left main lesions, new drug-eluting stents appear promising in the treatment of ULMCA disease in terms of safety and efficacy at 2-year clinical follow-up.
Despite the presence of complex...
06/04/2013
Journal of Invasive Cardiology
Original Contribution
08/29/2013
This study compares the long-term (2-year) clinical outcomes of everolimus-eluting (EES) and Resolute zotarolimus-eluting (R-ZES) stents in the treatment of coronary bifurcation lesions.
This study compares the long-term (2-year) clinical outcomes of everolimus-eluting (EES) and Resolute zotarolimus-eluting (R-ZES) stents in the treatment of coronary bifurcation lesions.
This study compares the...
08/29/2013
Journal of Invasive Cardiology
Original Contribution
07/15/2018
We aimed to define the frequency of anatomic variants and success rates during transradial access for PCI. These data provide reassurance for would-be radial converts that the learning curve may not be as steep as envisaged. 
We aimed to define the frequency of anatomic variants and success rates during transradial access for PCI. These data provide reassurance for would-be radial converts that the learning curve may not be as steep as envisaged. 
We aimed to define the frequency...
07/15/2018
Journal of Invasive Cardiology